Zepbound Cleared by FDA for Moderate to Severe Sleep Apnea in Obese Populations

Zepbound (tirzepatide), the first drug approved by the U.S. Food and Drug Administration (FDA), is used to treat moderate to severe obstructive sleep apnoea (OSA) in obese people. To be